GlassScriptPhysician profile
Shannon Davis
NPI 1508261702
$4,001.67
in general payments reported to CMS, 2019-2025
11 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $496 · 2023: $1,239 · 2024: $685 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,756 · Food and Beverage: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,756.47 |
| Food and Beverage | $1,536.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,756.47 | 2023-2025 | Cardiomems |
| Abbvie INC. | $921.05 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $509.59 | 2021-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $219.24 | 2023-2024 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $203.78 | 2022-2023 | |
| Neuronetics, INC. | $182.92 | 2023-2025 | Neurostar Tms Therapy System |
| Galderma Laboratories, L.P. | $145.00 | 2024 | |
| Corium, LLC | $18.07 | 2024 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $17.32 | 2022 | |
| Merck Sharp & Dohme LLC | $14.31 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.